| Literature DB >> 14993234 |
Matthias Versele1, Jeremy Thorner.
Abstract
Assembly at the mother-bud neck of a filamentous collar containing five septins (Cdc3, Cdc10, Cdc11, Cdc12, and Shs1) is necessary for proper morphogenesis and cytokinesis. We show that Cdc10 and Cdc12 possess GTPase activity and appropriate mutations in conserved nucleotide-binding residues abrogate GTP binding and/or hydrolysis in vitro. In vivo, mutants unable to bind GTP prevent septin collar formation, whereas mutants that block GTP hydrolysis do not. GTP binding-defective Cdc10 and Cdc12 form soluble heteromeric complexes with other septins both in yeast and in bacteria; yet, unlike wild-type, mutant complexes do not bind GTP and do not assemble into filaments in vitro. Absence of a p21-activated protein kinase (Cla4) perturbs septin collar formation. This defect is greatly exacerbated when combined with GTP binding-defective septins; conversely, the septin collar assembly defect of such mutants is suppressed efficiently by CLA4 overexpression. Cla4 interacts directly with and phosphorylates certain septins in vitro and in vivo. Thus, septin collar formation may correspond to septin filament assembly, and requires both GTP binding and Cla4-mediated phosphorylation of septins.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14993234 PMCID: PMC2172161 DOI: 10.1083/jcb.200312070
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 1.Purified Cdc10 and Cdc12 bind and hydrolyze GTP. (A) The indicated septin preparations (1–5 μg) were analyzed by SDS-PAGE and stained with Coomassie dye. (B) GTPase activity was measured by phosphate release from γ[32P]GTP for Cdc3 (⋄), Cdc10 (♦), Cdc11 (X) and Cdc12-His6 (•), and His6-GST (*). (C) GTPase activity of Cdc12-His6 (•), Cdc12ΔC-His6 (○), Cdc12(S43V)-His6 (▴), and Cdc12(T48N)-His6 (▪), as in B. (D) GTPase activity of Cdc12ΔC-His6 (○), Cdc12ΔC(S43V)-His6 (Δ), and Cdc12ΔC(T48N)-His6 (□), as in B. (E) [32P]GTPγS binding by His6-tagged Cdc12 (•), Cdc12(S43V) (▴), and Cdc12(T48N) (▪). (F) [32P]GTPγS binding by His6-tagged Cdc12ΔC (○), Cdc12ΔC(S43V) (Δ), and Cdc12ΔC(T48N) (□). For B–F, representative data are shown for experiments that were each repeated two to three (or more) times with different septin preparations and varying substrate or ligand concentrations.
Figure 2.GTP binding-dependent functions of Cdc12 and Cdc10 overlap. (A) Wild-type (BY4741) transformed with empty vector (YCplac33), cdc12(S43V) (YMVB2), cdc12(T48N) (YMVB1), cdc12(T48N) (YMVB1) carrying an episomal vector overexpressing cdc12(T48N) (pMVB49), and cdc12(T48N) (YMVB3) carrying a CEN plasmid with CDC12 (pMVB39), were grown at 30 or 37°C for 16 h under selective conditions. Cells were stained with DAPI and examined by Nomarski optics (differential interference contrast) or fluorescence microscopy (DAPI). Bar, 5 μm. (B) Wild-type (YMVB25), cdc10(S46N) (YMVB6), cdc12(T48N) (YMVB24), cdc10(S46N) cdc12(T48N) (YMVB8), and cdc10(S41V) cdc12(S43V) (YMVB60) cells were grown in YPD to mid-exponential phase at 26, 30, or 37°C, and morphology of the cells was examined by bright-field microscopy. Bar, 5 μm.
Figure 6.Synergistic roles for Cla4 phosphorylation and GTP binding in septin collar assembly. (A) A cla4Δ mutant (YMVB12), cdc12(T48N) (YMVB3), cla4Δ cdc12(T48N) (YMVB14), cdc12(T48N) cdc10(S46N) (YMVB50), and cla4Δ cdc12(T48N) cdc10(S46N) (YMVB51) were grown to mid-exponential phase on YPD at 26, 30, or 37°C, and examined by bright-field microscopy. (B) The cdc12(T48N) cdc10(S46N) (YMVB50) double mutant carrying either empty vector (YCplac33) or CEN vectors expressing CLA4 (pMVB113), SKM1 (YCpUG-Myc-SKM1), STE20 (pCJ160), or kinase-dead CLA4(K495A) (pMVB112) under control of the GAL1-promoter were grown on SC-Ura+Raf at 26°C overnight, transferred to SC-Ura+Gal for 3 h, shifted to 37°C, and examined as in A at the indicated times. Bars, 5 μm.
Figure 3.Septin–septin interactions do not require GTP binding. (A) Wild-type (BY4741) or cdc12(T48N) cells (YMVB3) transformed with CEN plasmids containing Cdc3-GFP, Cdc11-GFP (pSB5), or Cdc10-GFP (pLA-10) were grown to mid-exponential phase at 30°C and shifted to 37°C for 8 h. Extracts were subjected to immunoprecipitation with anti-Cdc12ΔC antibody. The inputs and resulting immune complexes were solubilized in SDS-PAGE sample buffer and analyzed by immunoblotting. (B) Cdc12-His6 and Cdc12(T48N)-His6 (0.1 μM) were incubated with 0.1 mM GTP for 1 h, and their ability to bind the indicated proteins (immobilized as GST fusions) was assessed. Input represents 20% of the total amount of Cdc12-His6 and Cdc12(T48N)-His6 initially added in each binding reaction. (C) Septin complexes were purified on Ni2+-saturated NTA-agarose from E. coli cells coexpressing His6-Cdc12 and the other septins indicated. Eluates were resolved on SDS-PAGE, stained with Coomassie blue. (D) GTP binding to the His6Cdc12–Cdc3–Cdc10–Cdc11 complex (•), the His6Cdc12(T48N)–Cdc3–Cdc10(S46N)–Cdc11 complex (▪), and His6-GST (negative control; ▴), immobilized on Ni2+-NTA beads. Values represent the average (error bars indicate the range) for the results of a typical experiment, where each measurement was performed in duplicate.
Figure 4.Septin filament assembly in vitro requires GTP binding. Filament formation of the indicated complexes (see Fig. 3 C) in elution buffer or after dialysis against low salt buffer was visualized by negative-stain transmission EM. Bars, 200 nm.
Figure 5.GTP binding is necessary for septin collar assembly. (A) Wild-type cells (BY4741) carrying CDC12-GFP (pLP29), and cdc10(S46N) cdc12(T48N) (YMVB8) expressing cdc12(T48N)-GFP (pMVB91) were grown to mid-exponential phase on SCD(-His) at 26°C, synchronized with α-factor, released and shifted to 37°C, and samples were taken at the indicated times. (B) The same strains as in A were grown to mid-exponential phase on SCD(-His) at 26°C, synchronized with hydroxyurea, released and shifted to 37°C, and samples were taken at the indicated times. BF, bright-field microscopy; GFP, fluorescence microscopy. Bar, 5 μm.
Figure 7.Cla4 phosphorylates septins. (A) NH2-terminally myc-tagged Cla4 (pMVB113) or Cla4(K495A) (pMVB112) were expressed in cla4Δ cells (YMVB12) and recovered by immunoprecipitation, and equal amounts, as verified by immunoblotting (outer right panel), were used in immune complex kinase assays, with the indicated substrates. Cdc12-His6 was present, but not resolved from the heavy (H) and light (L) chains of the anti-Myc mAb. The gel containing GST-Shs1 and GST-Shs1ΔC was run longer to ensure separation of GST-Shs1 from Cla4. (B) Wild-type cells carrying empty vector (YCplac33) or YCp-CDC10-GFP, and an isogenic cla4Δ mutant (YMVB12) carrying YCp-CDC10-GFP, were labeled with [32P]H3PO4, lysed, and the resulting extracts were subjected to immunoprecipitation with anti-GFP antibody. The precipitates were resolved by SDS-PAGE and incorporation was quantified using a PhosphorImager. Equal recovery of Cdc10-GFP was confirmed by immunoblotting (right). (C) The following strains, cdc10(S46N) (YMVB6), cdc10(S256A) (YMVB53), cdc10(S46N S256A) (YMVB54), and cdc10(S46N S256A) expressing CDC12-GFP, were grown at 26°C to mid-exponential phase, shifted to 37°C for 4 h, and viewed by differential interference contrast (left) or fluorescence microscopy (right). Bar, 5 μm.
Figure 8.GTP binding and Cla4-mediated phosphorylation in filament assembly and septin collar formation. The diagram summarizes our results (see Discussion), but is not meant to imply when GTP binding occurs (during nascent synthesis and folding of each individual septin, or at a later time) or a regulatory role for GTP-for-GDP exchange in triggering filament assembly.
Yeast strains used in this work
| Strain | Relevant genotype | Source/reference |
|---|---|---|
| BY4741 |
| Research Genetics, Inc. |
| YMVB1 | BY4741 | This paper |
| YMVB2 | BY4741 | This paper |
| YMVB3 | BY4741 | This paper |
| YMVB5 | BY4741 | This paper |
| YMVB15 | BY4741 | This paper |
| YMVB25 | BY4741 | This paper |
| YMVB24 | BY4741 | This paper |
| YMVB6 | BY4741 | This paper |
| YMVB8 | BY4741 | This paper |
| YMVB60 | BY4741 | This paper |
| YMVB12 | BY4741 | This paper |
| YMVB14 | BY4741 | This paper |
| YMVB48 | BY4741 | This paper |
| YMVB49 | BY4741 | This paper |
| YMVB50 | BY4741 | This paper |
| YMVB51 | BY4741 | This paper |
| YMVB53 | BY4741 | This paper |
| YMVB54 | BY4741 | This paper |
To replace the wild-type CDC12 locus with the GTPase mutants, pMVB21 or pMVB22 was digested with EcoRI and SpHI and transformed to BY4741. A PCR was performed to confirm correct replacement of CDC12 with the URA3 containing CDC12 cassette, and this PCR product was subsequently sequenced to verify introduction of the correct mutation.
Ura mutants were selected on agar medium containing 0.5 mg/ml 5-fluoro-orotic acid (Boeke et al., 1987).
The exact CDC10 open reading frame was deleted using the PCR-based “Short Flanking Homology” method, using vector pFA6, containing the kanMX4 cassette (Wach et al., 1994). The resulting PCR product was transformed into BY4741, YMVB1, or YMVB2, G418-resistant colonies were selected and replacement of the CDC10 ORF was verified by PCR.
The XhoI-digested pMVB41 (containing wild-type CDC10) was integrated at the promoter locus of CDC10 in YMVB5 and YMVB15. To replace the wild type CDC10 locus with the GTPase mutant, cdc10(S46N), the XhoI-digested pMVB40 was integrated at the promoter locus of CDC10 in YMVB5 or YMVB15. To replace the wild type CDC10 with the mutant, cdc10(S41V), the XhoI-digested pMVB155 was integrated in YMVB16 (BY4741 cdc10Δ cdc12(S43V)::URA3).
To delete CLA4, FD26, a construct described by Cvrckova et al. (1995) containing LEU2 as the selection marker, was transformed into BY4741 or YMVB3.
Marker swap plasmid pUH7 digested with SmaI (Cross, 1997) was used to replace the URA3 marker with HIS3 in YMVB1 and YMVB8.
To introduce the cdc10(S46N) mutant, YIplac211-cdc10(S46N) (YMVB69) was integrated at the CDC10 locus using the XhoI enzyme; Ura-transformants were selected on plates containing 5-FOA, and mutants were the cdc10(S46N) allele was retained, were selected: first by testing the temperature-sensitive phenotype of the mutants, then by sequencing.
To replace the wild type CDC10 locus with cdc10(S256A) or cdc10(S46N S256A) the XhoI-digested pMVB143 or pMVB144 was integrated at the promoter locus of CDC10 in YMVB5.
Plasmids used in this work
| Plasmid | Description | Source/reference |
|---|---|---|
| pMVB12 |
| This paper |
| pMVB13 |
| This paper |
| pMVB14 |
| This paper |
| pMVB15 |
| This paper |
| pMVB16 |
| This paper |
| pMVB17 |
| This paper |
| pMVB120 |
| This paper |
| pDT72 | pET24d-His6 vector | D. Truckses (this laboratory) |
| pBEG2 | His6- | B. Gullbrand (this laboratory) |
| pBEG3 | His6- | B. Gullbrand (this laboratory) |
| pMVB150 | His6- | This paper |
| pMVB151 | His6- | This paper |
| pKM263 | His6-GST vector |
|
| pMVB7 | His6-GST- | This paper |
| pMVB8 | His6-GST- | This paper |
| pMVB10 | His6-GST- | This paper |
| pGST-CDC11 | GST- | D. Kellogg (University of California, Santa Cruz, Santa Cruz, CA) |
| pMVB24 | GST- | This paper |
| pMVB25 | GST- | This paper |
| pMVB27 | GST- | This paper |
| pGEX-HSL1ΔN | GST- |
|
| pMVB80 | GST- | This paper |
| pMVB82 | GST- | This paper |
| pMVB81 | GST- | This paper |
| pMVB83 | GST- | This paper |
| pLP17 |
|
|
| pLP29 |
|
|
| pMVB32 |
| This paper |
| pMVB91 |
| This paper |
| pMVB19 | pUC18- | This paper |
| pMVB64 | pUC18- | This paper |
| pMVB65 | pUC18- | This paper |
| pMVB21 | pUC18- | This paper |
| pMVB22 | pUC18- | This paper |
| YCplac33 |
|
|
| pMVB39 |
| This paper |
| YEplac181 | 2 μm, |
|
| pMVB49 | 2 μm, | This paper |
| YIplac128 |
|
|
| pMVB41 |
| This paper |
| pMVB40 |
| This paper |
| pMVB155 |
| This paper |
| YIplac211 |
|
|
| pMVB69 |
| This paper |
| pMVB143 |
| This paper |
| pMVB144 |
| This paper |
| pLA10 |
|
|
| pSB5 |
| S. Bahmanyar (this laboratory) |
| CDC3-GFP |
| B. Haarer |
| pCJ160 |
|
|
| YCpUG-SKM1 |
|
|
| YEpUG-CLA4 | 2 μm, |
|
| pMVB113 |
| This paper |
| pMVB112 |
| This paper |
| pMVB121 | pETDuet-His6
| This paper |
| pMVB122 | pETDuet-His6
| This paper |
| pMVB123 | pACYDuet- | This paper |
| pMVB124 | pACYDuet- | This paper |
| pMVB125 | pETDuet-His6
| This paper |
| pMVB126 | pACYDuet- | This paper |
CDC12 was amplified using a forward primer, 5′-GGAATTCCAT AGTGCTGCCACTGC-3′ (NdeI site in italics, start codon in bold) and as reverse primer, 5′-TATCCGCTCGAGAGATCCACGTGGAACCAGTTTTAAATGGGATTTTTTTACTT-3′ (XhoI site in italics). CDC12(Δ339–407), abbreviated Cdc12ΔC, was amplified using the same forward primer and a different reverse primer, 5′-TATCCGCTCGAGAGAGCCACGCGGAACTAAGTGTGACAATTTCCTTGCT-3′. Both reverse primers encode a thrombin cleavage site. The resulting CDC12 and CDC12ΔC derivatives were inserted as NdeI–XhoI fragments into the corresponding sites of pET-24b (Novagen) upstream and in-frame with a His6 tag.
These constructs were created via site-directed mutagenesis of the indicated codons using mismatch primers.
Derived from pET-23d (Novagen).
The NcoI–BamHI fragment of pET-24d was replaced with an NcoI–BamHI fragment of pBH4 (a gift of K. Prehoda and W. Lim, UCSF) that contains six tandem His codons and a sequence encoding the cleavage site for TEV.
Derived from pDT72.
Derived from pKM263.
Derived from pGEX3 (Amersham Biosciences).
CDC12, including 500 bp of its promoter region, was amplified and inserted in pUC18. Mutations S43V and T48N were introduced separately into Cdc12, as described above. To permit subsequent integration at the CDC12 locus on chromosome VIII, 446 bp of the 3′-untranslated region of CDC12 was inserted in the corresponding constructs.
To provide a selectable marker for integration, the URA3 gene, excised from pJJ244 (Jones and Prakash, 1990) was inserted into the naturally occurring SnaBI site present in the 3′-flanking region of CDC12.
A fragment of pMVB19 carrying CDC12 and its promoter was inserted into the corresponding sites in YCplac33.
A fragment of pMVB22 carrying CDC12(T48N) and its promoter was inserted into the corresponding sites in YEplac181.
CDC10, including 500 bps of its promotor region and 250 bp 3′ to its stop codon, was amplified and cloned into YIplac128.
A fragment containing cdc10S46N and its promotor was subcloned from pMVB40 into YIplac211. The cdc10S256A mutation was introduced via site-directed mutagenesis.
The GAL1-Myc-CLA4 fragment from YEpUG-Myc-CLA4 was subcloned into YCplac33.
GAL1-Myc-CLA4 was subcloned from pMVB113 to pUC18, which was used as a template in a site directed mutagenesis reaction, changing Lys 594 to Ala; GAL1-Myc-CLA4(K594A) was then inserted into YCplac33.
These vectors are based on pETDuet-1 and pACYDuet-1 (Novagen). The His6 tag in pACYDuet was entirely deleted in pACYDuet1 using PCR mutagenesis. The GTP binding mutants were introduced by site-directed mutagenesis.